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Background: The concentration of extracellular nucleotides is regulated by enzymes that have their catalytic
site facing the extracellular space, the so-called ecto-enzymes.
Methods:We used LLC-PK1 cells, a well-characterized porcine renal proximal tubule cell line, to biochemically
characterize ecto-ATPase activity in the luminal surface. The [γ-32P]Pi released after reaction wasmeasured in
aliquots of the supernatant by liquid scintillation.
Results: This activity was linear with time up to 20 min of reaction and stimulated by divalent metals. The
ecto-ATPase activity measured in the presence of 5 mM MgCl2 was (1) optimum at pH 8, (2) insensitive to
different inhibitors of intracellular ATPases, (3) inhibited by 1 mM suramin, an inhibitor of ecto-ATPases,
(4) sensitive to high concentrations of sodium azide (NaN3) and (5) also able to hydrolyze ADP in the extra-
cellular medium. The ATP:ADP hydrolysis ratio calculated was 4:1. The ecto-ADPase activity was also
inhibited by suramin and NaN3. The dose–response of ATP revealed a hyperbolic proﬁle with maximal veloc-
ity of 25.2±1.2 nmol Pi xmg−1 xmin−1 and K0.5 of 0.07±0.01 mM.When cells were submitted to ischemia,
the E-NTPDase activity was reduced with time, achieving 71% inhibition at 60 min of ischemia.
Conclusion: Our results suggest that the ecto-ATPase activity of LLC-PK1 cells has the characteristics of a type
3 E-NTPDase which is inhibited by ischemia.
General Signiﬁcance: This could represent an important pathophysiologic mechanism that explains the
increase in ATP concentration in the extracellular milieu in the proximal tubule during ischemia.© 2012 Elsevier B.V. Open access under the Elsevier OA license. 1. Introduction
The concentration of extracellular nucleotides is tightly regulated by
enzymes that have their catalytic site facing the extracellular space,
the so-called ecto-enzymes [1–5]. These enzymes belong to the
ectonucleotidase family, which is subdivided into different groups:
(1) ecto-nucleotide pyrophosphatase phosphodiesterase (E-NPP);
(2) ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase);
(3) alkaline phosphatase; and (4) ecto-5′-nucleotidase [1–5]. In, Dulbecco's modiﬁed Eagle's
phohydrolase; E-NPP, ecto-nu-
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vier OA license. relation to the hydrolysis of nucleotide triphosphates such as ATP,
only the ﬁrst 3 classes of enzymes are responsible for its degradation.
E-NTPDases recognize both ATP and ADP as substrate; E-NPP hydro-
lyzes ATP directly to AMP and pyrophosphate. On the other hand, alka-
line phosphatase dephosphorylates a wide variety of phosphorylated
substrates [1–5].
There is a lot of evidence indicating the role of extracellular ATP
and adenosine (ADO) in renal function [6–9]. Vekaria et al. [10] dem-
onstrated that ATP is released in the proximal tubule and its concen-
tration decreases with time indicating the presence of ecto-enzymes
in this segment. This idea is supported by the observation that the
ﬁnal segment of the proximal tubule, the S3 portion, has a type 3
E-NPP (E-NPP3) as well as alkaline phosphatase in the luminal mem-
brane [11]. Furthermore, there is evidence of the presence of an
E-NTPDase-1 in a porcine renal cortex preparation [12].
During renal ischemia, a condition that is observed in different situ-
ations such as renal transplantation, release of cellular ATP occurs,
which could have both harmful and protective effects [13–15]. These
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metabolites with different receptors. It has been shown that glomerular
ecto-ATPase is markedly decreased in allograft renal transplantation
[16]. However, little is known about role of ecto-ATPases in proximal tu-
bule cells and their modulation under ischemic conditions.
The aim of the present work was to investigate the presence of
ecto-ATPase activity in proximal tubule cells and its modulation
under ischemic conditions. LLC-PK1 cells, a well-established model
of proximal tubule cells of pig kidney, were used. It was observed
that these cells present E-NTPDase activity in the luminal membrane
that is inhibited by ischemia. These results open new perspectives to
understanding the role of ecto-ATPases in renal function.2. Materials and methods
2.1. Materials
N-2-Hydroxyethylpiperazine N-2-ethanesulfonic acid (HEPES),
(trishydroxymethyl)-aminomethane (Tris), adenosine triphosphate
(ATP, sodium salt), adenosine diphosphate (ADP), adenosine 5′-
monophosphate (5′-AMP), adenosine, p-nitrophenyl-5′-thymidine
monophosphate (p-Nph-5′-TMP), β-glycerophosphate, and p-
nitrophenylphosphate (p-NPP), bovine serum albumin (BSA),
ethylenediamine tetraacetic acid (EDTA), Triton X-100, levamisole, so-
dium ﬂuoride, sodium tartrate, sodium orthovanadate, sodium azide,
suramin, and all chloride salts of zinc, magnesium, manganese and cal-
ciumwere purchased from Sigma Aldrich Co. (St. Louis, MO, USA). Lac-
tate dehydrogenase (LDH) activity colorimetric kit was purchased from
Gold Analisa Diagnóstica Ltda (Belo Horizonte, MG, Brazil). [32Pi]Pi was
obtained from the Brazilian Institute of Energetic and Nuclear Research,
São Paulo, Brazil. [γ-32Pi]ATP was synthesized according to the proce-
dures described by Maia et al. [17]. All other reagents were of the
highest purity available.2.2. LLC-PK1 cell culture
LLC-PK1 cells, a well-characterized porcine proximal tubule cell line,
were grown in 24-well plates (TPP) with low glucose Dulbecco's mod-
iﬁed Eagle's medium (DMEM) (Gibco) supplemented with 10% fetal
bovine serum (Gibco), 1% antibiotic/antimycotic (Gibco) at 37 °C/5%
CO2, for 48–72 h. After 95–98% conﬂuence, the cells were washed and
starved in serum-free medium for 4 h at 37 °C/5% CO2 before use in
the ecto-ATPase activity measurements. In the last 5 min of the starva-
tion period, the cells were pre-incubated with different compounds as
indicated in the ﬁgure legends.2.3. Measurement of ecto-ATPase activity
Intact monolayers of LLC-PK1 cells were incubated for 10 min at
room temperature in 0.3 mL of a reaction mixture containing, unless
otherwise speciﬁed, 20.0 mM HEPES–Tris buffer (pH 7.2), 116.0 mM
NaCl, 5.4 mM KCl, 5.0 mM glucose, 0.7 mM ATP in the absence or in
the presence of 5.0 mMMgCl2. The reaction was initiated by the addi-
tion of an ATP/[γ-32Pi]ATP mixture and stopped by adding 0.5 mL of
cold and activated charcoal with 0.1 N HCl. The [γ-32P]Pi released
was measured in aliquots of the supernatant obtained after centrifu-
gation at 2000 rpm for 5 min in a clinical centrifuge. The radioactivity
was determined by liquid scintillation (Packard Tri-Carb 2100 TR).
The ATPase activity was calculated by subtracting the nonspeciﬁc
ATP hydrolysis measured in the absence of cells.
When other nucleotides were used as substrate, the corresponding
hydrolytic activity was measured spectrophotometrically at 650 nm
[18]. Under the conditions described here, no phosphate precipitates
were observed in the presence of any cation.2.4. LDH assay
The activity of LDH was determined by a kinetic-UV method in the
supernatant of cells incubated with the reactionmixture used to mea-
sure ecto-ATPase activity, for 10 min at room temperature. The su-
pernatant was collected, and the LDH activity was detected in a
spectrophotometer at 450 nm each 30 s for 5 min of reaction. The ac-
tivity was determined as a percentage of the control, which was pre-
pared treating the monolayer with 1% Triton X-100.
2.5. Metabolic ischemia
Metabolic ischemia was accomplished by reversibly inhibiting
both glycolytic and oxidative metabolism, as described by Doctor
et al. [19]. After reaching conﬂuence, the cell cultures were washed
with 1× phosphate buffered saline and pre-incubated in a medium
without glucose (125 mM NaCl, 5 mM KH2PO4, 2 mM MgSO4, 25 mM
NaHCO3, 1.5 mMCaCl2 and 2 mMglutamine) for 3 h at 37 °C to reduce
the endogenous glycolytic substrate. The cellswere then incubatedwith
ATP depletion medium (the same composition as the pre-incubation
medium with 10 μM antimycin A, 10 mM 2-deoxyglucose, in the
absence of glutamine) for different times, as shown on the abscissa in
the ﬁgures. The cells were thenwashed and assayed for ecto-ATPase ac-
tivity using radiolabeled ATP (ATP/[γ-32Pi]ATP mixture) as described
above. The integrity of the cells after the induction of metabolic ische-
mia was maintained as shown by the detection of LDH activity in the
supernatant.
2.6. Statistical analysis
All experiments were performed in triplicate with different cell
suspensions. The number of cell suspensions represents the n value in-
dicated for each test. The means of the experiments were compared by
one-way analysis of variance (one-way ANOVA). The magnitude of the
differences was evaluated using the multiple comparative Newman–
Keuls test. Data are represented as the mean±standard error. The
values of K0.5 and the maximum velocity (Vmax) were calculated after
adjustment of experimental data by nonlinear regression using Sigma
Plot 10.0.
3. Results
3.1. Identiﬁcation of ecto-ATPase activity in LLC-PK1 cells
Initially, we veriﬁed whether monolayers of intact LLC-PK1 cells
were able to hydrolyze extracellular ATP. To avoid the possible effect
of growth factors on the ecto-ATPase activity, the cells were starved
for 4 h before any biochemical assay. A common feature of these en-
zymes is that they are usually activated by divalent cations, in partic-
ular Ca2+ or Mg2+ [2]. Fig. 1A shows the effect of different divalent
cations (Mg2+, Ca2+, Mn2+ or Zn2+) on the ecto-ATPase activity of
LLC-PK1 cells. All cations were tested as a chloride salt at a ﬁnal con-
centration of 5 mM, except CaCl2, which was 1 mM. Mg2+ and Ca2+
were able to stimulate the ecto-ATPase activity when compared
with the activity measured in the absence of any cation or in the
presence of 1 mM EDTA. Signiﬁcant ecto-ATPase activity was ob-
served even without addition of divalent metals showing the pres-
ence of these ions in the medium. The addition of ZnCl2 decreased
the activity of ecto-ATPase compared with the activity measured in
the absence of 1 mM EDTA. On the other hand, Mn2+ stimulated
ecto-ATPase activity but less effectively than Ca2+ and Mg2+. The
ecto-ATPase activity determined in the presence of 5 mM MgCl2
was 13.3±0.5 nmol Pi mg−1 min−1. The activity observed without
the addition of MgCl2 was less than 5% of total ecto-ATPase activity
(in the presence of 5 mM MgCl2). The time course of ecto-ATPase ac-
tivity was linear for at least up to 20 min of reaction (Fig. 1B). Based
Fig. 1. Measurement of ecto-ATPase activity in LLC-PK1 cells. (A) Inﬂuence of divalent cations on the ecto-ATPase activity of LLC-PK1 cells. Intact cells were incubated in 24-well
plates with ATP, as described in Section 2, in the absence or in the presence of 5 mM ZnCl2, 5 mM MnCl2, 1 mM CaCl2 or 5 mM MgCl2. A control condition without any metals
but with 1 mM EDTA was also included. The data are expressed as the mean±SE (n=3). *Signiﬁcantly different from the control with EDTA. #Signiﬁcantly different from the con-
trol without EDTA. (B) Time course of LLC-PK1 ecto-ATPase activity. Intact cells were incubated in the same reaction medium, in the presence of 5 mMMgCl2, for different times as
depicted on the abscissa. The data are expressed as the mean±SE (n=3). (C) Measurement of LDH activity in the supernatant of disrupted cells (black bar) or intact cells (white
bar). Intact cells were incubated in the same reaction medium, in the presence of 5 mMMgCl2, for 10 min. The supernatant was collected for the determination of LDH activity using
a colorimetric kit, as described in Section 2. The activity was determined as a percentage of the control, which was obtained by treating the intact monolayers with 1% Triton X-100
(black bar). (D) Apoptotic/necrotic proﬁle of LLC-PK1 cells after incubation with DMEM without serum. Intact cells were starved for 4 h and subsequently stained with annexin
V-FITC and PI, following the manufacturer's instructions. The percentage of annexin V- and PI-positive cells was determined by ﬂow cytometry.
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reaction.
The inﬂuence of secreted ATPase on the ecto-ATPase activity was
also evaluated. Cell monolayers were incubated with the reaction
mixture without substrate. The supernatant was then harvested and
checked for its ability to hydrolyze extracellular ATP in the presence
or in the absence (with 1 mM EDTA) of 5 mMMgCl2. We detected se-
creted Mg2+-dependent ATPase activity but it represented only 15%
of the total Mg2+-stimulated ecto-ATPase activity (data not shown).
In addition, the supernatant was used to determine the activity of
LDH, a cytosolic enzyme that can be found in the extracellular medi-
um in the case of loss of cell integrity. All results showed LDH activity
less than 5% compared with a control treated with 1% Triton X-100 for
40 min (Fig. 1C). The monolayer was stained with annexin V-FITC, a
marker of early apoptosis, and propidium iodide (PI), a marker of
late apoptosis and necrosis [20,21]. Approximately 10% of cells were
stained with annexin V and PI (Fig. 1D). These data indicate that cel-
lular integrity was not affected by the experimental conditions.
3.2. Biochemical characterization of ecto‐ATPase activity in LLC-PK1 cells
The optimum pH for the ecto-ATPase activity present in LLC-PK1
cells was 8.0 (Fig. 2A). Further increase in pH decreased the ecto-
ATPase activity to values similar to those found in the acid range.
One of themain characteristics of ecto-ATPases is insensitivity to in-
hibitors of P-, V- or F-type ATPases [2]. To exclude the possibility that
the hydrolysis of extracellular ATP, under the experimental conditions
used, could be due to these enzymes, several inhibitors of different clas-
ses of ATPases that have their ATP binding site inside the cell were test-
ed (Fig. 2B). We observed that Mg2+-dependent ecto-ATPase activity
was insensitive to 1 mM NaF and 1 mM sodium tartrate, inhibitors ofacid phosphatase and secreted phosphatase, respectively [22,23]. Like-
wise, 1 mM ouabain, a classic inhibitor of (Na++K+)ATPase [24], and
0.5 mM vanadate, an inhibitor of P-ATPase [25], also failed to inhibit
the ecto-ATPase activity present in LLC-PK1 cells. On the other hand,
0.5 mM suramin, an inhibitor of ecto-ATPase [26], inhibited the
ecto-ATPase activity 76%. The addition of 1 or 10 mM levamisole, an in-
hibitor of alkaline phosphatase [27], stimulated ecto-ATPase activity
2-fold. The stimulatory effect of levamisole had the same magnitude
whether we used 1 or 10 mM levamisole. Fig. 2C shows that sodium
azide (NaN3), a potent inhibitor of mitochondrial Mg2+-ATPase [28],
inhibited ecto-ATPase activity only at high concentrations (6–10 mM),
as seen for other type 1 and 3 E-NTPDases [12,29–31].
Fig. 3A shows the substrate curve of the ecto-ATPase activity in the
presence of 10 mM levamisole to avoid the possible contribution of
alkaline phosphatase activity. The kinetic parameters were calculated
using the Lineweaver–Burk double reciprocal plot, by plotting 1/v
against 1/ATP analyzed over a range of ATP concentrations
(0.01–2 mM) (Fig. 3B). The ATP concentration that promotes a half
maximal effect (K0.5) was 0.07±0.01 and the maximum rate (Vmax)
was 25.2±1.2 nmol Pi xmg−1 xmin−1. In addition, the effect of dif-
ferent substrates of ectonucleotidases on the ecto-ATPase activity was
tested (Fig. 3C). The addition of 5′-AMP, a substrate of 5′-adenosine
nucleotidase, the ﬁnal product of AMP dephosphorylation and
5′-TMP, a speciﬁc substrate of E-NPP [32], did not inﬂuence the
ecto-ATPase activity. On the other hand, β-glycerophosphate, a sub-
strate of alkaline phosphatase, as well as p-NPP, an unspeciﬁc sub-
strate of different types of phosphatases [22,23], enhanced this
activity in a similar way to that observed when levamisole was used.
Fig. 3C shows that the addition of 1 mM ADP, a substrate of
E-NTPDase, inhibited the ecto-ATPase activity. Fig. 3D shows the effect
of different ADP concentrations (0.1–2.0 mM) on the ecto-ATPase
Fig. 2. (A) Effect of pH on the ecto-ATPase activity of LLC-PK1 cells. Intact cells were in-
cubated in 24-well plates with ATP, as described in Section 2, in a pH range from 5 to 9
(Tris–HCl buffer adjusted to different pH values). The data are expressed as the
mean±SE (n=3). (B) Inﬂuence of inhibitors of different classes of enzymes on the
ecto-ATPase activity of LLC-PK1 cells. Intact cells were incubated in 24-well plates
with ATP, as described in Section 2 in the presence of 1 mM ouabain (Ouab), 1 mM so-
dium orthovanadate (Van), 1 mM sodium ﬂuoride (NaF), 1 mM sodium tartrate (Tart),
1 mM levamisole (Lev 1), 10 mM levamisole (Lev 10) or 1 mM suramin (Sur). The data
are expressed as the mean±SE (n=3). *Signiﬁcantly different from the control.
(C) Dose–response of sodium azide on the ecto-ATPase activity of LLC-PK1 cells. Intact
cells were incubated in 24-well plates with ATP, as described in Section 2 in the ab-
sence or in the presence of increasing concentrations of sodium azide (NaN3), from 1
to 10 mM. The data are expressed as the mean±SE (n=3). *Signiﬁcantly different
from the control.
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crease in ADP concentration promoted inhibition of ecto-ATPase activi-
ty with the maximal effect observed at 1 mM. The inhibitory effect of
ADP was not changed by the addition of levamisole (insert of Fig. 3D).
Levamisole promoted the same stimulation of ecto-ATPase activity at
all ADP concentrations tested.So far, our results indicate that the ecto-enzyme expressed in
LLC-PK1 cells is also able to hydrolyze ADP. To conﬁrm this hypothe-
sis, we measured the formation of Pi in the extracellular medium in
the presence of different ratios of ATP:ADP in the presence of
10 mM levamisole (Fig. 4A). A decrease in Pi release in the extracellu-
lar medium when the ATP:ADP ratio is decreased indicates that this
enzyme preferably hydrolyzes ATP rather than ADP. The ATP:ADP hy-
drolysis ratio calculated was 4:1. To be sure that the same enzyme
was hydrolyzing both ATP and ADP, we tested the effect of levami-
sole, suramin and NaN3 on the activity of ADPase (Fig. 4B and C).
This activity was stimulated by 1 or 10 mM levamisole and inhibited
by 0.5 mM suramin similar to the ecto-ATPase activity (Fig. 4B). We
also observed that 10 mM NaN3 inhibited ecto-ADPase activity by
about 50% (Fig. 4C). This effect is similar to that observed for
ecto-ATPase activity (Fig.2C). However, a lower NaN3 concentration
(e.g. 4 mM) decreased ecto-ADPase activity but did not change
ecto-ATPase activity. The results indicate that extracellular ATP hy-
drolysis is catalyzed by an E-NTPDase, which is able to hydrolyze
both ATP and ADP.
3.3. Regulation of ecto-ATPase activity by ischemia
Renal ischemia is one of the main causes of acute renal failure [33].
The level of intra- and extracellular nucleotides is altered in an ischemic
situation; therefore, it is plausible to postulate that the ecto-ATPase ac-
tivity could be modulated. To test this hypothesis, the LLC-PK1 cells
were exposed to chemical ischemia using 2-deoxyglucose and
antimycin A for different times up to 60 min. The ecto-ATPase activity
was measured by the addition of 0.7 mM ATP. Fig. 5A shows that the
ecto-ATPase activity was decreased by ischemia in a time-dependent
manner. At 60 min of ischemia, 71% inhibitionwas observed. The possi-
bility that this inhibition could be due to a decrease in cell viability could
be ruled out as revealed by the LDH activity detected in the supernatant
(Fig. 5B).
4. Discussion
It is well established that the extracellular level of nucleotides is
crucial to modulate renal proximal tubule function [6–9]. Control of
the extracellular ATP level by ecto-ATPases becomes a limiting step
to determine its ﬁnal effect. However, little is known about the pres-
ence of ecto-ATPases and their modulation in this segment. In the
present study, we characterized ecto-ATPase activity correlated to
E-NTPDase in LLC-PK1 cells, a well-established model of renal proxi-
mal tubule cells, which is inhibited by ischemia. These results open
new avenues to understanding the metabolism of extracellular ATP
and determination of its ﬁnal effects on proximal tubule function.
Ecto-ATPases are enzymes characterized by the external location
of the site that hydrolyzes ATP (1–5). Here we observed that the
ATPase activity measured in the luminal side of LLC-PK1 cells is
assigned to an ecto-ATPase activity because (1) cell viability was
maintained throughout the experimental procedure because low
levels of LDH activity were detected in the supernatant of cells after
incubation with the reaction mixture; (2) ATP hydrolysis was linear
with time, for at least 20 min of reaction; (3) ATP hydrolysis correlat-
ed to secreted enzymes was less than 10% of the total ecto-ATPase ac-
tivity; (4) inhibitors of different intracellular ATPases were not able to
reduce the ecto-ATPase activity; (5) the ecto-ATPase activity was
stimulated by divalent cations, mainly Ca2+ and Mg2+.
Following the biochemical characterization of this enzyme, we
also found other interesting aspects that corroborate the idea of the
presence of an ecto-ATPase activity in the surface of LLC-PK1 cells.
For instance, the fact that inhibitors of acidic phosphatases were not
able to inhibit the ecto-ATPase activity, together with the optimum
pH in the alkaline range, could rule out the possible involvement of
such phosphatases in the extracellular ATP hydrolysis by LLC-PK1
Fig. 3. (A) Dose–response of ATP on the ecto-ATPase activity of LLC-PK1 cells in the presence of 10 mM levamisole. Intact cells were incubated in 24-well plates in the same reaction
mixture described in Section 2 in the presence of increasing concentrations of ATP as shown on the abscissa. The data are expressed as the mean±SE (n=3). (B) Lineweaver–Burk
plot based on the data from (A). (C) Inﬂuence of different substrates on the ecto-ATPase activity of LLC-PK1 cells. Intact cells were incubated in 24-well plates in the same reaction
mixture described in Section 2, in the presence of 1.0 mM ADP, 0.5 mM 5′-AMP, 0.5 mM adenosine (ADO), 0.5 mM β-glycerophosphate (β-Gly), 0.5 mM p-NPP or 0.5 mM 5′-TMP
for 5 min, prior to the start of the reaction with ATP. The data are expressed as the mean±SE (n=3). *Signiﬁcantly different from the control. (D) Dose–response of ADP on the
ecto-ATPase activity of LLC-PK1 cells in the presence (○) or in the absence (●) of 1 mM levamisole. Intact cells were incubated in 24-well plates in the same reaction mixture de-
scribed in Section 2, in the presence of 1.0 mM levamisole and increasing concentrations of ADP as depicted on the abscissa, for 5 min, before the start of the reaction with ATP. The
data are expressed as the mean±SE (n=3). The inset shows the inhibition of ecto-ATPase activity induced by ADP in the presence (white bar) or in the absence (black bar) of
1 mM levamisole. *Signiﬁcantly different from the control without levamisole. #Signiﬁcantly different from the control with levamisole.
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obtained in present work is that levamisole, a classic inhibitor of alka-
line phosphatases, increased the ecto-ATPase activity. Alkaline phos-
phatases can recognize a variety of substrates including adenine
nucleotides [4]; therefore, we can speculate that these enzymes, to-
gether with ecto-ATPase, could participate in the hydrolysis of the
extracellular ATP. Then, the inhibition of alkaline phosphatase by
levamisole could increase the substrate availability for the ecto-
ATPase activity. This hypothesis is strengthened by the observation
that β-glycerophosphate and p-NPP, more effective substrates for
alkaline phosphatase than ATP, also increased the ecto-ATPase
activity.
Picher et al. [34] showed that a nonspeciﬁc alkaline phosphatase in
the airway is completely inhibited only by 10 mM levamisole. Here,
we observed that levamisole increased the ecto-ATPase activity and
this effect was the same with 1 or 10 mM levamisole indicating that
LLC-PK1 cell alkaline phosphatase is more sensitive to levamisole than
that observed in the airway. In agreement with this view, Martins
et al. [35] showed that 1 mM levamisole completely inhibits tissue-
nonspeciﬁc alkaline phosphatase (TNALP) in the renal cortex. In addi-
tion, they observed that renal TNALP is more sensitive to levamisole
than hepatic TNALP [35]. The possibility that the ecto-ATPase activity
measured in LLC-PK1 cells is correlated to alkaline phosphatase can be
ruled out.Two different types of ectonucleotidases able to hydrolyze extra-
cellular ATP have been described: E-NPPs and E-NTPDases, which in-
clude E-NTPDase 1, 2, 3 and 8 [1–5]. Vekaria et al. [11] showed the
presence of an E-NPP3 in the S3 portion of renal proximal tubules
using an immunohistochemical assay. E-NPP3 is an enzyme that
uses only ATP as substrate to generate 5′-AMP and PPi [5]. In contrast,
here we observed that the ecto-ATPase activity was not changed by
5′-TMP, a speciﬁc substrate for E-NPPs, or by 5′-AMP, the ATP hydro-
lysis product generated by E-NPP activity and a substrate for
ecto-5′-nucleotidase. Thus, the hydrolysis of extracellular ATP driven
by LLC-PK1 cells is not due to any E-NPPase.
Ectonucleotidases have been immunolocalized along the rat neph-
ron, the proximal tubule rich in E-NPP and 5′-nucleotidase, whereas
the expression of type 3 E-NTPDase is observed in the thick ascending
limb of Henle, the distal tubule and the collecting duct [11]. The
ecto-enzyme present in the luminal membrane of LLC-PK1 cells is able
to hydrolyze ATP and ADP, resembling E-NTPDase activity. Using a cor-
tex preparation from pig kidneys, Lemmens et al. [12] characterized an
ecto-ATPDase activity identiﬁed as E-NTPDase1, similar to the CD39
found in immune cells. The sensitivity to NaN3 has been used as an im-
portant tool to characterize type 1 and 3 E-NTPDases [12,29–31]. In ad-
dition, it has been shown that ecto-ATPDase activity is inhibited by
NaN3 in the cortex of pig kidney [12]. The authors showed that NaN3 in-
hibits ecto-ADPase activity more strongly than ecto-ATPase activity.
Fig. 4. (A) Detection of ecto-ATPDase activity on the surface of LLC-PK1 cells (Chevilard
plot) in the presence of 10 mM levamisole. Intact cells were incubated in 24-well
plates in the same reaction mixture described in Section 2 in the presence of different
ratios of ATP:ADP as depicted on the abscissa, for the spectrophotometric detection of
ectonucleotidase activity. The data are expressed as the mean±SE (n=3). (B) The ef-
fect of levamisole and suramin on the ecto-ADPase activity of LLC-PK1 cells. Intact cells
were incubated in 24-well plates with ADP, as described in Section 2 in the presence of
1 mM levamisole (Lev 1 mM), 10 mM levamisole (Lev 10 mM) or 1 mM suramin. The
ecto-ADPase activity was detected spectrophotometrically at 650 nm as described in
Section 2. The data are expressed as the mean±SE (n=3). *Signiﬁcantly different
from the control. (C) Dose–response of sodium azide on the ecto-ADPase activity of
LLC-PK1 cells. Intact cells were incubated in 24-well plates with ADP, as described in
Section 2 in the absence or in the presence of increasing concentrations of sodium
azide (NaN3), from 1 to 10 mM. The data are expressed as the mean±SE (n=3).
*Signiﬁcantly different from the control.
Fig. 5. (A) Modulation of the ecto-ATPase activity from LLC-PK1 cells by ischemia. Intact
cells were pre-incubated in 24-well plates with a mixture containing 125 mmol NaCl,
5 mmol KH2PO4, 2 mmol MgSO4, 25 mmol NaHCO3, 1.5 mmol CaCl2 and 2 mmol gluta-
mine, for 3 h at 37 °C, prior to incubationwith ATP depletionmedium, to inducemetabol-
ic ischemia. Cells were then used to measure the ecto-ATPase activity using radiolabeled
ATP (ATP/[γ-32Pi]ATP mixture) as described in Section 2. The data are expressed as the
mean±SE (n=3). *Signiﬁcantly different from the control. (B) Measurement of LDH ac-
tivity in the supernatant of disrupted cells (black bar) or intact cells (white bar) before and
after metabolic ischemia. Intact cells were submitted or not to metabolic ischemia as de-
scribed in Section 2. The supernatant was collected for the determination of LDH activity
using a colorimetric kit, as described in Section 2. The activity was determined as a per-
centage of the control (100%), which was obtained by treating the intact monolayers
with 1% Triton X-100 to disrupt the cells.
2035M.C. Ribeiro et al. / Biochimica et Biophysica Acta 1820 (2012) 2030–2036Similar results were obtained in human brain [29] and in the present
work. Thus, the observation that E-ATPDase activity in the luminal
side of LLC-PK1 cells is inhibited by NaN3 indicates that it belongs to
type 1 or 3 E-NTPDase. This hypothesis is strengthened by the observa-
tion that ZnCl2, an inhibitor of type 1 or 3 E-NTPDase [36], inhibited the
activity of ecto-ATPase in LLC-PK1 cells. One important characteristicthat distinguishes E-NTPDase 1 and 3 is the ATP:ADP hydrolysis ratio
[1–5,30]. Here, the ATP:ADP hydrolysis ratio was 4:1 which indicates
that the E-NTPDase expressed in the luminal side of LLC-PK1 cells is
possibly type 3. However, the possible involvement of type 1
E-NTPDase cannot be ruled out. Another important issue that should
be pointed out is the renal physiological signiﬁcance of the type 3
E-NTPDase found in LLC-PK1 cells. These cells are well known as a
goodmodel to study the function of proximal tubule cells at themolec-
ular level. In this way, the results obtained for the LLC-PK1 cell line
could represent an important avenue for further research on under-
standing the role of ecto-E‐NTPDase in proximal tubule cells.
In the present work, we observed that the decrease in ecto-ATPase
activity was dependent on the time that the cells underwent ischemic
insult. These data corroborate with the decreased expression of a glo-
merular ecto-ATPase observed in rats after allograft transplantation
[16]. Similarly, in kidney biopsies of patients with nephropathy due
to chronic graft, decreased glomerular E-NTPDase expression was
also observed [37]. The mechanism involved in the inhibition of
ecto-ATPase during ischemia has not yet been completely elucidated.
Indeed, with the assay used, all ecto-ATPases are inhibited by ische-
mia. Further experiments are necessary to clarify this issue.
The luminal concentration of ATP depends on the tonic nucleotide
release and its hydrolysis by ecto-enzymes [6]. Usually, there is a high
2036 M.C. Ribeiro et al. / Biochimica et Biophysica Acta 1820 (2012) 2030–2036gradient concentration of ATP between the intracellular and extracel-
lular milieu favouring ATP efﬂux [6]. It has been proposed that the
luminal ATP concentration in proximal tubules ranges from the
nanomolar level up to the micromolar level during tubule injury
[14]. We have shown that the apparent afﬁnity (K0.5) for ATP is in
the micromolar range, indicating that this enzyme plays an important
role in decreasing the ATP level during renal injury. Lu et al. [38]
showed that the deletion of CD39 (E-NTPDase1) in mice induces se-
vere renal injury and that the administration of soluble CD39 has a
protective role in renal tissue during ischemia.
Extracellular nucleotides can bind to speciﬁc purinergic receptors
controlling different cell functions. ATP interacts speciﬁcally with
ionotropic P2X and metabotropic P2Y receptors. Since there are many
types of P2X and P2Y receptors expressed in proximal tubule cells in
brush-border and basolateral membranes, the speciﬁc function of
each receptor type in renal function is still an open matter [6–9].
However, it is well known that higher ATP concentrations have been
proposed to work as a danger signal, thereby leading to cell death
[39]. On the other hand, lower ATP concentrations are involved in the
modulation of renal function (e.g. hydroelectrolytic balance) [6,7].
Thus, the possible association between alkaline phosphatase and
E-NTPDase activities could play an important role in determining the
ﬁnal concentration of ATP in proximal tubule cells, avoiding the delete-
rious effect induced by a high level of ATP in proximal tubule cells.
5. Conclusion
In this work we have characterized the biochemical properties of
ecto-ATPase activity in LLC-PK1 cells that allowed us to correlate it
to a type 3 E-NTPDase. This activity was signiﬁcantly inhibited by is-
chemia, which could represent an important pathophysiologic mech-
anism involved in the increase of extracellular ATP concentration.
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